eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
2/2021
vol. 38
 
Share:
Share:
more
 
 
abstract:
Original paper

Safety of bronchodilator reversibility test in elderly subjects: a prospective study

Anna Dor-Wojnarowska
1
,
Anna Parużyńska
2
,
Aleksandra Kulczak
2
,
Marta Majewska-Pulsakowska
1
,
Małgorzata Szymala-Pędzik
2
,
Zbigniew Machaj
2
,
Małgorzata Sobieszczańska
2
,
Małgorzata Poręba
3

1.
Department and Clinic of Internal Medicine and Allergology, Wroclaw Medical University, Wroclaw, Poland
2.
Department and Clinic of Geriatrics, Wroclaw Medical University, Wroclaw, Poland
3.
Department of Pathophysiology, Wroclaw Medical University, Wroclaw, Poland
Adv Dermatol Allergol 2021; XXXVIII (2): 256-261
Online publish date: 2020/02/01
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The reversibility test measures an increase in ventilation parameters after the administration of 400 mg of a short-acting b-agonist (SABA). It is worth noting that a typical dosage, applied as a rescue medicine for bronchospastic dyspnoea, is significantly less, i.e., 100–200 mg.

Aim
To assess the effects of inhaled 400 mg fenoterol (in the bronchodilator reversibility test) on the heart rate and the development of tachyarrhythmias in subjects aged 65 and above.

Material and methods
A total of 53 subjects (45 women) aged 77; 68–82 (median; interquartile range) in stable clinical condition were included in the study. Data including medical history, physical examinations, blood biochemistry, chest X-ray, 12-lead electrocardiogram, 24-hour Holter ECG monitoring, bronchodilator test, and echocardiography were obtained. During the Holter ECG monitoring, the bronchodilator test using 400 mg fenoterol (Berotec pMDI) was performed.

Results
A slight but statistically significant (p = 0.02) increase in heart rate from 71 to 75 per min (median) was noted after the administration of fenoterol. No statistically significant differences were found in the number of extrasystolic beats of either supraventricular (p = 0.42) or ventricular origin (p = 0.50). In addition, the subjects did not show any potentially dangerous arrhythmias or significant signs of coronary artery disease. However, there was a significant increase in the number of supraventricular beats in the subjects who were not taking β-blockers.

Conclusions
The use of 400 mg fenoterol in a bronchodilator reversibility test in elderly subjects does not entail any significant cardiovascular risk.

keywords:

24-hour Holter ECG monitoring, bronchodilator test, elderly subjects

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe